Algeta schedules first half and second quarter 2013 results presentation, webcast and conference call
August 19, 2013 - Oslo, Norway
Algeta ASA (OSE: ALGETA), a company focusedonthe development of novel targeted cancer therapeutics, will announce itsfirsthalf and second quarter 2013 results on Wednesday, 28 August2013. Apresentation by members of Algeta's executive management team toinvestors,analysts and the press will take place in Oslo at 10:00 CET.
The presentation will also be webcast live and can be accessedthroughwww.algeta.com where questions can also be submitted during thepresentation.
The presentation will take place at 10:00 CET at:
Haakon VIIs gate 9
Algeta will also host an international conference call at 14:30CET/08:30Eastern Time (US) (details below).
To participate in the conference call, please dial the appropriate numberbelowfive minutes prior to the call:
US: +1 877 423 0830
UK: +44 20 7153 9154
Norway: +47 21 06 61 13
Sweden: +46 8-506 443 86
Denmark: +45 32 71 42 62
Switzerland: +41 44 580 65 22
Participant pin code: 197187#
To access the replay, please dial:
US: +1 877 679 2989
UK: +44 203 364 5200
Norway: +47 23 50 02 03
Sweden: +46 8-505 564 73
Conference reference: 348084#
A replay of the conference call will also be available at www.algeta.com.
The results report and the presentation will be available atwww.algeta.com inthe Investors section from 07:00 CET.
Algeta is a company focused on developing novel targeted therapies forpatientswith cancer based on its alpha-pharmaceutical platform. The Company isheadquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,based inCambridge, MA performing commercial marketing operations in the US. Algetaislisted on the Oslo Stock Exchange (Ticker: ALGETA). For more informationpleasevisit www.algeta.com.
This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE
For further information, please contact:
Mike Booth / Renate Birkeli
Communications & Corporate Affairs
+47 23 00 67 32
Citigate Dewe Rogerson
+44 207 638 9571
Gambit Hill & Knowlton
+47 22 04 82 00
MacDougall Biomedical Communications
+1 781 235 3060
The Trout Group
+1 646 378 2953